Global Immunodiagnostics Market Will Rise at a CAGR of 4.7%; Rise In Geriatric Population Is Likely To Fuel Demand, says Fortune Business Insights

The increasing number of geriatric populations, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the global immunodiagnostics market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2019-2026,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2026.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444

Global Immunodiagnostics Market Report 2019 -2026 contains systematic and point to point information regarding to Immunodiagnostics Industry. The report contains brief Introduction, Market analysis by types , applications and regions.Report also contains top Manufacturers Profiles (Name of the manufacturer, Business Overview, Type and Applications and Sales, Price, Revenue, Gross Margin and Market Share).Report also provide global and regional Sales Channel, Distributors, Traders and Dealers with Pressure Sensors Market Analysis Value And next four Years forecast value.

Global " Immunodiagnostics Market " 2020 report includes the market strategy, market orientation, expertise opinion and knowledgeable information. Report provides market growth and Revenue, market share and size that helps to understand future prospects. The report also covers the current market information, porter's five forces analysis with threat of new entrants, threat of substitute products and services, key challenges, opportunities in Microbiome Therapeutics Industry.

Key Industry Developments

In March 2019, Oncimmune announced the acquisition of Protagen Diagnostics.
In November 2018, Ortho Clinical Diagnostics received U.S FDA approval for the company’s VITROS HIV Combo test, an immunodiagnostic detect HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag).
In May 2016, Diasorin announced the acquisition of Quest Diagnostics’ immunodiagnostics products.
The immune system of a human is one of the most complex networks. Recent advancements in global immunodiagnostics market have improvised diagnosis of this complex network. A rise in infectious diseases like HIV, cancer, hepatitis, and other cardiovascular diseases is aiding expansion of the immunodiagnostics market. Furthermore, advancements in technology will stoke growth of the global immunodiagnostics market during the forecast period. The report provides an in-depth analysis of various factors that have contributed to the growth of the global immunodiagnostics market.

Quick Buy

https://www.fortunebusinessinsights.com/checkout-page/100444

Oncology and Endocrinology Segment Will Witness Increasing Demand

The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunodiagnostics-market-100444

Asia Pacific to Remain Dominant in the Market

The global immunodiagnostics market can be geographically segmented into Latin America, North America, Asia Pacific, Middle East, Europe and Africa. Amongst these regions, the Asia Pacific market was worth US$ 3,949.1 Mn in 2017, and it is still likely to generate a comparatively high CAGR during the forecast period. As there is an increasing awareness among the masses regarding disease management, it encourages them to go for regular health check-ups and tests. This has also enhanced the global immunodiagnostics market.

Moreover, an increasing number of players in the region, rising awareness, and advancements in health care industry will drive the immunodiagnostics market in Asia Pacific. It is anticipated that China and India will exhibit high demand for immunodiagnostics in Asia Pacific. This is because of the presence of unmet medical needs in the region. The immunodiagnostics market in the Middle East and Latin America is projected to expand considerably by the end of 2025, because of the rise in infectious and cardiovascular diseases in these regions.

Secondary Data Sources That We Refer To
Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
Industry journals and paid databases
Secondary Research Is Conducted To Derive The Following Information
Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
Number of procedures and average price of procedures
Replacement rate and pricing of capital equipment
Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
Market & technological trends, new product developments, product pipeline.
Some of the leading companies that are operating in the global immunodiagnostics market are

Abbott,
Hoffmann-La Roche AG (Roche Diagnostics),
DiaSorin,
Danaher Corporation,
QIAGEN,
bioMérieux,
Thermo Fisher Scientific,
Quest Diagnostics.
Segmentation

By Product

Instruments
Reagents & Consumables
By Application

Oncology & Endocrinology
Hepatitis & Retrovirus
Cardiac Markers
Infectious Diseases
Others
By End user

Clinical Laboratories
Hospitals
Physician’s Offices
Others
By Geography

North America (USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Abbott, DiaSorin, and Roche Diagnostics are Likely to Hold Significant Share in the Market

Prominent organizations such as Abbott, DiaSorin, and Roche Diagnostics are projected to lead the global immunodiagnostics market during the forecast period. Development strategies, rise in the investments in research and development, cost management, and strong supply chain network are predicted to give impetus to these companies and enable them gain a competitive edge.

Highlights of the Report

In-depth analysis of various insights, namely, Immunodiagnostics Market, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and market shares.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com

This release was published on openPR.